DE60139399D1 - Gpr8 ligand und dafuer kodierende dna - Google Patents

Gpr8 ligand und dafuer kodierende dna

Info

Publication number
DE60139399D1
DE60139399D1 DE60139399T DE60139399T DE60139399D1 DE 60139399 D1 DE60139399 D1 DE 60139399D1 DE 60139399 T DE60139399 T DE 60139399T DE 60139399 T DE60139399 T DE 60139399T DE 60139399 D1 DE60139399 D1 DE 60139399D1
Authority
DE
Germany
Prior art keywords
gpr8
dafuer
ligand
encoding dna
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60139399T
Other languages
English (en)
Inventor
Masaaki Mori
Yukio Shimomura
Mioko Harada
Mika Goto
Chieko Kitada
Taiji Asami
Yoshio Matsumoto
Yuka Adachi
Takuya Watanabe
Tsukasa Sugo
Michiko Abe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60139399D1 publication Critical patent/DE60139399D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60139399T 2000-06-21 2001-06-20 Gpr8 ligand und dafuer kodierende dna Expired - Lifetime DE60139399D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000191089 2000-06-21
JP2000275013 2000-09-06
JP2001116000 2001-04-13
PCT/JP2001/005257 WO2001098494A1 (fr) 2000-06-21 2001-06-20 Ligand de gpr8 et son adn

Publications (1)

Publication Number Publication Date
DE60139399D1 true DE60139399D1 (de) 2009-09-10

Family

ID=27343845

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60139399T Expired - Lifetime DE60139399D1 (de) 2000-06-21 2001-06-20 Gpr8 ligand und dafuer kodierende dna

Country Status (7)

Country Link
US (2) US7193033B2 (de)
EP (1) EP1293567B1 (de)
AT (1) ATE437949T1 (de)
AU (1) AU2001274562A1 (de)
CA (1) CA2413195C (de)
DE (1) DE60139399D1 (de)
WO (1) WO2001098494A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE371863T1 (de) 2001-05-15 2007-09-15 Takeda Pharmaceutical Screening-verfahren
ATE400584T1 (de) * 2001-06-14 2008-07-15 Takeda Pharmaceutical Neuer ligand und dna davon
WO2003057236A1 (fr) * 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Inhibiteur de prise de poids corporel
WO2003081234A2 (en) * 2002-03-26 2003-10-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8)
WO2003082907A1 (en) * 2002-03-29 2003-10-09 Euroscreen Sa Ligands for g protein coupled receptor gpr7 and uses thereof
AU2003277553A1 (en) * 2002-11-06 2004-06-07 Takeda Pharmaceutical Company Limited Antidiuretics
JP2004292444A (ja) * 2003-03-13 2004-10-21 Takeda Chem Ind Ltd 上部消化管疾患の予防・治療剤
JP4504098B2 (ja) * 2003-05-28 2010-07-14 武田薬品工業株式会社 抗体およびその用途
WO2004106382A1 (ja) * 2003-05-28 2004-12-09 Takeda Pharmaceutical Company Limited 抗体およびその用途
CN101631454A (zh) 2006-12-08 2010-01-20 衣阿华州立大学研究基金公司 参与硝酸盐吸收和代谢的植物基因
KR20100061679A (ko) * 2007-09-11 2010-06-08 몬도바이오테크 래보래토리즈 아게 치료적 적용을 위한 티로트로핀 방출 호르몬

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5591602A (en) * 1993-11-05 1997-01-07 O'dowd; Brian F. Nucleic acid encoding opioid receptor
JPH09121865A (ja) 1995-10-30 1997-05-13 Takeda Chem Ind Ltd 新規ｇ蛋白質共役型レセプター蛋白質、その製造法および用途
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
EP1304376A4 (de) 2000-07-25 2004-12-29 Takeda Chemical Industries Ltd Verfahren zur herstellung eines rekombinanten proteins
EP1344823A4 (de) 2000-11-30 2005-03-16 Takeda Chemical Industries Ltd Neue g-protein-gekoppelte rezeptorproteine und deren dnas
ATE371863T1 (de) 2001-05-15 2007-09-15 Takeda Pharmaceutical Screening-verfahren

Also Published As

Publication number Publication date
US20050153391A1 (en) 2005-07-14
EP1293567B1 (de) 2009-07-29
ATE437949T1 (de) 2009-08-15
US7193033B2 (en) 2007-03-20
EP1293567A4 (de) 2005-02-16
WO2001098494A1 (fr) 2001-12-27
CA2413195C (en) 2012-01-17
CA2413195A1 (en) 2002-12-17
EP1293567A1 (de) 2003-03-19
US20080305998A1 (en) 2008-12-11
AU2001274562A1 (en) 2002-01-02
US7671174B2 (en) 2010-03-02

Similar Documents

Publication Publication Date Title
DE60139399D1 (de) Gpr8 ligand und dafuer kodierende dna
ATE127474T1 (de) Neue peptidasen und isomerasen-inhibitoren.
HUP0402315A2 (hu) VII-es faktor polipeptidek folyékony gyógyszerkészítménye
DK1576112T3 (da) Cytokin-receptor zcytor17-multimerer
DE69435268D1 (de) Menschliche metabotropische rezeptoren, diese kodierende nukleinsäure und ihre verwendung
IS6785A (is) EP4 viðtakahindrar til meðhöndlunar á liðagigt
ATE337191T1 (de) Doppelbrechende markierung
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
DK15589D0 (da) Kemiske forbindelser
SE8801275D0 (sv) New uses of dopamine agonists
ITMI20020773A0 (it) Farmaci per il trattamento dell'artrite
ATE390482T1 (de) Interleukin-1 hy2. mittel und verfahren
ATE548350T1 (de) N-arylpiperidin-substituierte biphenylcarbonsäureamide als inhibitoren von apolipoprotein b
DE60332579D1 (de) Prozess zur Immobilisierung von Polypeptiden über die Carboxylgruppe des C-terminus
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
FI900083A (fi) Nya tetralinderivat.
ATE139570T1 (de) Expression signalpeptid-freier staphylokinasen
ATE270551T1 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4- dicarbonsäure und paracetamol
ATE304995T1 (de) Stoffgemisch enthaltend bisphenol a
SE9701409D0 (sv) Treatment of rheumatoid arthritis
BRPI0413718A (pt) ativadores de plasminogênio tendo uma capacidade reduzida de ligar lisina
ATE299491T1 (de) Benzoltricarbonsäureamide als aktivatoren des insulinrezeptors
DK1083224T3 (da) Apoptin-associerende protein
DE60033146D1 (de) Inhibitorprotein der transkriptionsaktivierung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition